Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-08 Sale |
2021-10-12 6:43 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
302 | $25.02 | $7,555 | 1,223,053 (Indirect Direct) |
View |
| 2021-09-10 Sale |
2021-09-14 4:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
2,593 | $22.15 | $57,435 | 73,964 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 6:53 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
5,833 | $25.24 | $147,237 | 1,221,515 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 5:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $25.25 | $147,301 | 1,223,355 (Indirect Direct) |
View |
| 2021-08-11 Sale |
2021-08-12 5:27 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
621 | $25.15 | $15,619 | 1,227,348 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 5:26 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
2,020 | $25.07 | $50,636 | 1,229,188 (Indirect Direct) |
View |
| 2021-08-06 Sale |
2021-08-10 4:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
3,829 | $25 | $95,725 | 1,227,969 (Direct) |
View |
| 2021-08-06 Sale |
2021-08-10 4:53 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
2,443 | $25.01 | $61,088 | 1,231,208 (Indirect Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:16 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
1,383 | $25 | $34,577 | 1,231,798 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:14 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
1,370 | $25 | $34,250 | 1,233,651 (Indirect Direct) |
View |
| 2021-06-23 Sale |
2021-06-25 9:30 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
55,684 | $29.79 | $1,658,842 | 2,987,331 (Indirect) |
View |
| 2021-06-21 Sale |
2021-06-25 8:51 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
201,620 | $29.05 | $5,856,114 | 3,043,015 (Indirect) |
View |
| 2021-05-07 Sale |
2021-05-07 8:01 pm |
Tarsus Pharmaceuticals Inc. | TARS | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
450,000 | $29.98 | $13,491,000 | 2,013,601 (Indirect) |
View |
| 2021-04-14 Sale |
2021-04-16 9:07 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
400 | $30.37 | $12,148 | 3,244,635 (Indirect) |
View |
| 2020-10-20 Purchase |
2020-10-20 8:01 pm |
Tarsus Pharmaceuticals Inc. | TARS | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
312,500 | $16 | $5,000,000 | 1,917,157 (Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:59 pm |
Tarsus Pharmaceuticals Inc. | TARS | Horowitz Limited Partnership VIII 10% Owner |
184,375 | $16 | $2,950,000 | 1,987,105 (Indirect Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:58 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
250,000 | $16 | $4,000,000 | 3,245,035 (Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:56 pm |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
171,875 | $16 | $2,750,000 | 1,920,933 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-10 Exercise |
2021-09-14 4:51 pm |
N/A 2030-09-24 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,350 | $10.99 | 73,964 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-14 4:51 pm |
N/A 2028-09-13 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
2,593 | $0.45 | 73,964 (Direct) |
View |
| 2021-08-11 Option Award |
2021-08-12 7:28 pm |
N/A 2031-08-11 |
Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:28 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:26 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:25 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:21 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:20 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 7:19 pm |
N/A 2031-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
24,257 | $0 | 1,257,438 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 8:14 pm |
N/A 2031-03-02 |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
14,300 | $0 | 14,300 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-02 7:57 pm |
N/A 2031-02-02 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
89,368 | $0 | 89,368 (Direct) |
View |
Ownership |
2021-01-21 1:24 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
0 | $0 | 5,000 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:58 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
40,999 | $0 | 40,999 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:57 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
61,499 | $0 | 61,499 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:55 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
40,999 | $0 | 40,999 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:53 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
204,998 | $0 | 204,998 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:49 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
89,368 | $0 | 89,368 (Direct) |
View |
| 2020-11-19 Option Award |
2020-11-23 7:00 pm |
N/A 2030-11-18 |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-10-26 2:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
0 | $0 | 2,463,601 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 8:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
1,604,657 | $0 | 1,917,157 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:59 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Horowitz Limited Partnership VIII 10% Owner |
1,802,730 | $0 | 1,987,105 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:58 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
2,995,035 | $0 | 3,245,035 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:57 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
1,112,301 | $0 | 1,246,933 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:56 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
1,777,456 | $0 | 1,920,933 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:54 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director 10% Owner |
63,185 | $0 | 1,228,924 (Direct) |
View |